FDFT1
protein-codingfarnesyl-diphosphate farnesyltransferase 1
Gene summary
This gene encodes a membrane-associated enzyme located at a branch point in the mevalonate pathway. The encoded protein is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~43.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032566
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032566
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0019200
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032566
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032566
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FDFT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004462.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 26 | 2 | 29 | ||
| missense | 102 | 5 | 2 | 109 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 2 | 105 | 31 | 4 | 142 |
Highest pathogenic variant AF is 0.0000021592396
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004453.3 | 8 | MANE Select | |
| Ensembl | ENSP00000220584.4 | 8 | MANE Select | |
| RefSeq | NP_001274671.1 | 8 | Standard | |
| RefSeq | NP_001274672.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid biosynthesis - Homo sapiens (human)
- Bisphosphonate Pathway, Pharmacodynamics
- Statin Pathway, Pharmacodynamics
- Simvastatin Action Pathway
- Pravastatin Action Pathway
Biological Process
- steroid biosynthetic process
- cholesterol biosynthetic process
- ergosterol biosynthetic process
- isoprenoid biosynthetic process
- regulation of lipid metabolic process
Molecular Function
- farnesyl-diphosphate farnesyltransferase activity
- protein binding
- squalene synthase activity
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000220584
- Coding exons
- 8
- Length
- 43737
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 48
- Defined
- 125748
- p
- 0.000191
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -3.88 | 408 | 239 | 1.71 | 0.0000129 | 2754 |
| Missense (PolyPhen) | 105 | 78.436 | 1.3387 | 962 | ||
| Synonymous | -7.30 | 172 | 86.0 | 2.00 | 0.00000452 | 768 |
| Loss of Function | -0.394 | 21 | 19.1 | 1.10 | 8.96e-7 | 233 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000095 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00025 | 0.00025 | rare |
| South Asian | 0.00010 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.267
Intolerance Scores
- LoFtool
- 0.320
- RVIS EVS
- -1.13
- RVIS percentile EVS
- 6.48
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |